Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Insight

Illustration of over-the-counter products

Why the resurgence of POM-to-P reclassifications in the UK is a good thingSubscription

By

After a dwindle in the number of reclassifications of prescription-only to pharmacy medicines in the UK, things are starting to look up, writes Natalie Gauld.

CPD article

Scanning electron micrograph (SEM) of tuberculosis (TB) bacteria infecting macrophages

Fluoroquinolones for treating tuberculosisSubscription

By , ,

Tuberculosis (TB) remains a significant global health and socioeconomic challenge. The duration of current anti-TB therapies, the adverse effects of certain anti-TB drugs and the growing problem of drug-resistant TB on an international scale mean that it is imperative for new, effective and safe treatment regimens to be developed. Fluoroquinolones are a class of drugs that have been used in the treatment of TB for several decades. This article provides an overview of the current treatment ...

Review

Micrograph of Acinetobacter baumannii bacteria

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitorSubscription

By , ,

Over the past decade, infections caused by multidrug-resistant Gram-negative organisms have increased. The limited availability in treatment options for these infections prompted both the UK to create a five-year antimicrobial resistance strategic plan to stimulate the development of new antibiotics, and the Infectious Diseases Society of America to call for ten new antimicrobial agents to be developed by 2020. Ceftazidime-avibactam is a combination of a third-generation ...

Short communications

Advice to give to asthma patients about air pollutionSubscription

By

Two-thirds of people with asthma in the UK say poor air quality makes their asthma worse, which puts them at higher risk of an asthma attack.

Too early to tell if vitamin D has a role in reducing the common coldSubscription

By

Community pharmacists are repeatedly asked for recommendations to reduce the risk of catching a cold. The advertising of novel products such as nasal sprays, gargles, face masks and a plethora of potential protective botanical products can cause confusion about what really might be useful and appropriate.

A quick intervention recommendation by community pharmacists for patients using inhalersSubscription

By

Many pharmacists are probably busy reviewing inhaler use and technique as part of their medicines use reviews and new medicine service processes for patients with asthma and chronic obstructive pulmonary disease (COPD).

Care for children with diabetes is improving, but there is more work to do

By

For the seventh year running, the National Paediatric Diabetes Audit shows that children living with diabetes are being helped to manage their blood glucose levels (HbA1c) and so reduce the risk of developing ...

Developing guidelines for the safe handling of cytotoxic drugs in academic research laboratoriesSubscription

By , ,

The bench-to-bedside approach to healthcare involves a continuous iterative process whereby practice-based challenges are examined, researched and addressed in an effort to optimise patient care. This is supported through fostering collaborations and partnerships between healthcare professionals and academic researchers.

Research briefing

Xray showing hip joint

Risk of fracture from benzodiazepine and Z-drugs higher for short-term usersSubscription

15 MAY 2017

Meta analysis shows that fracture risk is highest among new users of both benzodiazepines and Z-drugs.

MRI scan showing intracranial haemorrhage

Intracranial haemorrhage risk of warfarin unrelated to INR controlSubscription

21 APR 2017

Study results show that choosing apixaban over warfarin could reduce the risk of anticoagulation-related intracranial haemorrhage.

Scanning electron micrograph of a dying cancer cell

Anti-rheumatic works with anti-cancer drug to boost tumour cell deathSubscription

20 APR 2017

Researchers find that auranofin and RAPTA-T can work together to kill tumour cells.

Boy staring at an open page book

ADHD drug shows promise for treating dyslexiaSubscription

20 APR 2017

Researchers find that attention-deficit hyperactivity disorder drug atomoxetine could benefit children with dyslexia.

Clinical Pharmacist

CP May 2017, Vol 9, No 5

Cover Story:

Fluoroquinolones for treating tuberculosis

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.